These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15678792)

  • 21. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
    Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV
    BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
    Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
    Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and risk for acute hepatitis C infection during imprisonment in Australia.
    Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson W; Kaldor J; Lloyd A; Haber P
    Eur J Epidemiol; 2010 Feb; 25(2):143-8. PubMed ID: 20084429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie.
    Bird AG; Gore SM; Cameron S; Ross AJ; Goldberg DJ
    AIDS; 1995 Jul; 9(7):801-8. PubMed ID: 7546427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
    Taylor A; Goldberg D; Hutchinson S; Cameron S; Gore SM; McMenamin J; Green S; Pithie A; Fox R
    J Infect; 2000 Mar; 40(2):176-83. PubMed ID: 10841096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
    Bird AG; Gore SM; Hutchinson SJ; Lewis SC; Cameron S; Burns S
    BMJ; 1997 Jul; 315(7099):21-4. PubMed ID: 9233321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland.
    Gore SM; Bird AG; Burns S; Ross AJ; Goldberg D
    Int J STD AIDS; 1997 Mar; 8(3):166-75. PubMed ID: 9089027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Jailbreak Health Project--incorporating a unique radio programme for prisoners.
    Minc A; Butler T; Gahan G
    Int J Drug Policy; 2007 Oct; 18(5):444-6. PubMed ID: 17854735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C transmission through tattooing: a case report.
    Thompson SC; Hernberger F; Wale E; Crofts N
    Aust N Z J Public Health; 1996 Jun; 20(3):317-8. PubMed ID: 8768424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates.
    Li H; Cameron B; Douglas D; Stapleton S; Cheguelman G; Butler T; Luciani F; Lloyd AR
    Vaccine; 2020 Apr; 38(16):3255-3260. PubMed ID: 32151462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.
    Peña-Orellana M; Hernández-Viver A; Caraballo-Correa G; Albizu-García CE
    J Health Care Poor Underserved; 2011 Aug; 22(3):962-82. PubMed ID: 21841290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
    PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours.
    Gore SM; Bird AG; Cameron SO; Hutchinson SJ; Burns SM; Goldberg DJ
    QJM; 1999 Jan; 92(1):25-32. PubMed ID: 10209669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.
    Vescio MF; Longo B; Babudieri S; Starnini G; Carbonara S; Rezza G; Monarca R
    J Epidemiol Community Health; 2008 Apr; 62(4):305-13. PubMed ID: 18339822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug injection and HIV prevalence in inmates of Glenochil prison.
    Gore SM; Bird AG; Burns SM; Goldberg DJ; Ross AJ; Macgregor J
    BMJ; 1995 Feb; 310(6975):293-6. PubMed ID: 7866170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group.
    Ford PM; Pearson M; Sankar-Mistry P; Stevenson T; Bell D; Austin J
    QJM; 2000 Feb; 93(2):113-9. PubMed ID: 10700482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
    Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
    Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort.
    Teutsch S; Luciani F; Scheuer N; McCredie L; Hosseiny P; Rawlinson W; Kaldor J; Dore GJ; Dolan K; Ffrench R; Lloyd A; Haber P; Levy M
    BMC Public Health; 2010 Oct; 10():633. PubMed ID: 20964864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.